ISARIC has been committed to provide a wide breadth of COVID-19 clinical research resources since the beginning of the outbreak. These resources are fully adaptable and completely free to use
The tools below aim to cover a range of tiers, suitable for different needs. Whether you are aiming to just collect standardised data, contribute with your data to ISARIC’s ever growing clinical database or start your own study on COVID-19, ISARIC’s COVID-19 presents fully adaptable data collection solutions for different needs.
Professor Bin Cao with a COVID-19 patient (Photo credit: Professor Bin Cao, China-Japan Friendship Hospital, China)
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Visit this section to find ISARIC’s articles, studies and more.
“Genetic evidence is second only to clinical trials as a way to tell which treatments will be effective in a disease.”
The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
In January 2020, ISARIC launched an international initiative for standardised COVID-19 clinical data collection. Over the past nine months, there has been extensive global participation, resulting in one of the world’s largest collections of comprehensive clinical data for COVID-19.